Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Royalty Pharma Plc Cl A (RPRX)

Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
LASR
3 Overrated Stocks We Steer Clear Of StockStory - Wed Dec 31, 10:37PM CST

3 Overrated Stocks We Steer Clear Of

RPRX : 39.65 (+2.03%)
LASR : 38.09 (-0.73%)
CRL : 208.32 (+2.91%)
Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones GlobeNewswire - Mon Dec 29, 2025

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired the final portion of PTC Therapeutics’ remaining royalty on Roche’s Evrysdi for...

RPRX : 39.65 (+2.03%)
PGNY
3 Healthcare Stocks We’re Skeptical Of StockStory - Tue Dec 16, 2025

3 Healthcare Stocks We’re Skeptical Of

RPRX : 39.65 (+2.03%)
PGNY : 26.66 (+3.57%)
ANIP : 78.66 (+0.29%)
Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million GlobeNewswire - Tue Dec 16, 2025

NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a pre-existing royalty interest in Nuvalent’s neladalkib and zidesamtinib from an...

RPRX : 39.65 (+2.03%)
Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement GlobeNewswire - Thu Dec 4, 2025

NEW YORK and SOUTH SAN FRANCISCO, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Denali Therapeutics, Inc. (Nasdaq: DNLI) today announced a $275 million synthetic royalty...

RPRX : 39.65 (+2.03%)
DNLI : 16.02 (-1.54%)
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement GlobeNewswire - Thu Dec 4, 2025

SOUTH SAN FRANCISCO, Calif. and NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) and Royalty Pharma plc (Nasdaq: RPRX) today announced a $275 million synthetic royalty...

RPRX : 39.65 (+2.03%)
DNLI : 16.02 (-1.54%)
CHD
3 Mid-Cap Stocks That Concern Us StockStory - Wed Dec 3, 2025

3 Mid-Cap Stocks That Concern Us

RPRX : 39.65 (+2.03%)
FHN : 24.57 (+1.82%)
CHD : 84.11 (+1.78%)
Royalty Pharma to Present at Upcoming Investor Conferences GlobeNewswire - Wed Nov 26, 2025

NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of December: ...

RPRX : 39.65 (+2.03%)
ST
3 Value Stocks with Warning Signs StockStory - Mon Nov 17, 2025

3 Value Stocks with Warning Signs

ST : 35.21 (+0.92%)
RPRX : 39.65 (+2.03%)
OMC : 78.35 (-3.65%)
CBRL
3 Low-Volatility Stocks We Find Risky StockStory - Sun Nov 16, 2025

3 Low-Volatility Stocks We Find Risky

RPRX : 39.65 (+2.03%)
ACT : 40.31 (+1.74%)
CBRL : 26.55 (-1.12%)

Barchart Exclusives

Stock Index Futures Muted as Rally Stalls, U.S. Economic Data Awaited Barchart - 1 minute ago
March S&P 500 E-Mini futures (ESH26) are down -0.06%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.07% this morning, taking a breather after the AI-driven rally seen in the first trading days of 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot